methylprednisolone has been researched along with Alport Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aydin, S; Gillion, V; Godefroid, N; Jadoul, M | 1 |
Bachelet, T; Couzi, L; Guerville, F; Lepreux, S; Merville, P; Moreau, K; Morel, D | 1 |
Frimas, C; Karpouzas, J; Psimenos, G | 1 |
3 other study(ies) available for methylprednisolone and Alport Syndrome
Article | Year |
---|---|
ANCA vasculitis in a patient with Alport syndrome: a difficult diagnosis but a treatable disease!
Topics: Adolescent; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Combined Modality Therapy; Cyclophosphamide; Diagnosis, Differential; Diagnostic Errors; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Nephritis, Hereditary; Plasmapheresis; Treatment Outcome | 2017 |
Transplantation with pathologic kidneys to improve the pool of donors: an example of shunt nephritis.
Topics: Adolescent; Antibodies, Monoclonal; Basiliximab; Fatal Outcome; Glomerular Filtration Rate; Humans; Hydrocephalus; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Methylprednisolone; Mycophenolic Acid; Nephritis, Hereditary; Recombinant Fusion Proteins; Tacrolimus; Tissue Donors; Treatment Outcome; Ventriculoperitoneal Shunt; Young Adult | 2012 |
Hereditary nephritis associated with nephrotic syndrome.
Topics: Azathioprine; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Humans; Kidney; Male; Methylprednisolone; Nephritis, Hereditary; Nephrotic Syndrome | 1974 |